Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals
4/30/2008 7:43:22 AM
More...
|
BioRelix, Inc. and Dalton Medicinal Chemistry Partners Sign Research Agreement to Capitalize on RiboSwitch Technology
11/14/2007 7:22:46 AM
More...
|
BioRelix, Inc. and Dalton Medicinal Chemistry Partners Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
11/13/2007 2:43:57 PM
More...
|
BioRelix, Inc. Announces $25.75 Million Series A Financing to Fund Development of Antibiotic Product Pipeline
6/8/2007 1:44:13 PM
More...
|